Cargando…
Non-ABO red cell antibodies and risk of COVID-19
It is not known whether non-ABO antibodies confer any protective effect against SARS-CoV-2 infection or COVID-19 severe illness alone or in conjunction with O blood group. This cohort study included 413 576 persons in Ontario, Canada with known ABO blood group and non-ABO antibody screen status, who...
Autores principales: | Ray, Joel G., Colacci, Michael, Schull, Michael J., Vermeulen, Marian J., Park, Alison L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132504/ https://www.ncbi.nlm.nih.gov/pubmed/34022334 http://dx.doi.org/10.1016/j.ijid.2021.05.038 |
Ejemplares similares
-
ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study
por: Ray, Joel G., et al.
Publicado: (2021) -
ABO blood groups, COVID-19 infection and mortality()()
por: Lehrer, Steven, et al.
Publicado: (2021) -
ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population
por: Padhi, Sunali, et al.
Publicado: (2020) -
SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study
por: Ray, Joel G, et al.
Publicado: (2022) -
Major Radiodiagnostic Imaging in Pregnancy and the Risk of Childhood Malignancy: A Population-Based Cohort Study in Ontario
por: Ray, Joel G., et al.
Publicado: (2010)